Boots
This article was originally published in The Tan Sheet
Executive Summary
Novartis Consumer Health named Clearasil distributor in U.S., Canada effective July 2 to strengthen position of skin care brand, UK firm announces. Former Clearasil marketer Procter & Gamble will distribute brand until July 1 and continue to manufacture it in North America until further notice, Boots says. Novartis and Boots will work together to evaluate opportunities for Clearasil, including revamping the line and possibly bringing other Boots OTCs under development in UK to U.S. market, firm says. Boots purchased Clearasil from P&G for $340 mil. (1"The Tan Sheet" Oct. 23, 2000, p. 7)
You may also be interested in...
Novartis Consumer Health Reshuffled, Functional Foods On Sales Block
Novartis is reorganizing its consumer health division by grouping together three businesses - OTC drugs, infant and baby and medical nutrition - and operating animal health and Ciba Vision as separate units, the firm stated during a year-end analysts call Feb. 7
Novartis Consumer Health Reshuffled, Functional Foods On Sales Block
Novartis is reorganizing its consumer health division by grouping together three businesses - OTC drugs, infant and baby and medical nutrition - and operating animal health and Ciba Vision as separate units, the firm stated during a year-end analysts call Feb. 7
Novartis Consumer Health Reshuffled, Functional Foods On Sales Block
Novartis is reorganizing its consumer health division by grouping together three businesses - OTC drugs, infant and baby and medical nutrition - and operating animal health and Ciba Vision as separate units, the firm stated during a year-end analysts call Feb. 7